LOW DOSE COLCHICINE COMBINED WITH SPORADIC INTRAMUSCULAR INJECTIONS OF BETAMETHASONE - EFFICIENT AND SUSTAINED TREATMENT OF ACUTE GOUTY ARTHRITIS

被引:0
|
作者
Sargsyan, A. [1 ]
Vardanyan, V. [1 ,2 ]
Ginosyan, K. [1 ]
Vardanyan, S. [2 ]
Mukuchyan, V. [3 ]
机构
[1] Yerevan State Med Univ, Yerevan, Armenia
[2] Mikayelyan Inst Surg, Yerevan, Armenia
[3] Erebouni Med Ctr, Yerevan, Armenia
关键词
D O I
10.1136/annrheumdis-2020-eular.3762
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
THU0440
引用
收藏
页码:453 / 453
页数:1
相关论文
共 50 条
  • [41] LIFE THREATENING ACUTE PNEUMONITIS DURING LOW-DOSE METHOTREXATE TREATMENT FOR RHEUMATOID-ARTHRITIS - A CASE-REPORT AND REVIEW OF THE LITERATURE
    RIDLEY, MG
    WOLFE, CS
    MATHEWS, JA
    ANNALS OF THE RHEUMATIC DISEASES, 1988, 47 (09) : 784 - 788
  • [42] Combined Low-Dose Contrast-Enhanced MR Angiography and Perfusion for Acute Ischemic Stroke at 3T: A More Efficient Stroke Protocol
    Nael, K.
    Meshksar, A.
    Ellingson, B.
    Pirastehfar, M.
    Salamon, N.
    Finn, P.
    Liebeskind, D. S.
    Villablanca, J. P.
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2014, 35 (06) : 1078 - 1084
  • [43] Successful treatment with low-dose gemtuzumab ozogamicin-combined chemotherapy followed by unrelated stem cell transplantation for children with refractory acute myeloid leukaemia
    Yoshida, N.
    Sakaguchi, H.
    Matsumoto, K.
    Kato, K.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S150 - S150
  • [44] Efficacy and safety of low-dose glucocorticoids combined with methotrexate and hydroxychloroquine in the treatment of early rheumatoid arthritis A single-center, randomized, double-blind clinical trial
    Hua, Li
    Du, Hongwei
    Ying, Mingliang
    Wu, Honghua
    Fan, Jia
    Shi, Xiaowei
    MEDICINE, 2020, 99 (27) : E20824
  • [45] Efficacy and Safety of Azacytidine Combined with Low-Dose Lenalidomide in Preemptive Treatment of Post Allo-SCT Acute Myeloid Leukemia Patients with Detectable Minimal Residual Disease
    Wang, Lu
    Feng, Yimei
    Gao, Lei
    Kong, Peiyan
    Zhang, Xi
    BLOOD, 2022, 140 : 12933 - 12933
  • [46] Low-dose X-ray radiodynamic therapy solely based on gold nanoclusters for efficient treatment of deep hypoxic solid tumors combined with enhanced antitumor immune response
    Zhu, Shengcang
    Yan, Feihong
    Yang, Lulu
    Li, Bingyi
    Xue, Ruxian
    Yu, Wenwen
    Wang, Yu
    Huang, Lu
    Wang, Lijun
    Han, Rongcheng
    Jiang, Yuqiang
    THERANOSTICS, 2023, 13 (03): : 1042 - 1058
  • [47] Low-dose cytarabine and aclarubicin combined with granulocyte colony-stimulating factor for the treatment of relapsed or primary refractory acute lymphocytic leukemia: a retrospective study of 25 Chinese patients
    Xue, Sheng-Li
    Cui, Hong-Xia
    Zou, Jing-Ying
    Xue, Meng-Xing
    Tang, Xiao-Wen
    Zhang, Yan-Ming
    Wu, De-Pei
    HEMATOLOGICAL ONCOLOGY, 2013, 31 (04) : 206 - 212
  • [48] Cladribine Combined with Low-Dose Cytarabine as Frontline Treatment for Unfit Elderly Acute Myeloid Leukemia Patients: Results from a Prospective Multicenter Study of Polish Adult Leukemia Group (PALG)
    Budziszewska, Bozena Katarzyna
    Salomon-Perzynski, Aleksander
    Pruszczyk, Katarzyna
    Barankiewicz, Joanna
    Pluta, Agnieszka
    Helbig, Grzegorz
    Janowska, Anna
    Kuydowicz, Marta
    Bolkun, Lukasz
    Piszcz, Jaroslaw
    Patkowska, Elzbieta
    Watek, Marzena
    Malecki, Piotr
    Kosciolek-Zgodka, Sylwia
    Cichocka, Edyta
    Charlinski, Grzegorz
    Irga-Staniukiewicz, Anna
    Zaucha, Jan Maciej
    Piekarska, Agnieszka
    Gromek, Tomasz
    Hus, Marek
    Wojcik, Karol
    Razny, Malgorzata
    Sedzimirska, Mariola
    Pula, Bartosz
    Giebel, Sebastian
    Grosicki, Sebastian
    Wierzbowska, Agnieszka
    Lech-Maranda, Ewa
    CANCERS, 2021, 13 (16)
  • [49] Treatment of Relapsed ACUTE Leukemia after ALLO-HSCT By Salvage Chemotherapy with Low-Dose Cytarabine and Aclarubicin Combined with G-CSF Priming: More Effective and LESS Toxic?
    Hua Zhou
    Ling Ge
    Xiaming Zhu
    Huiying Qiu
    Zhengming Jin
    Miao Miao
    Chengcheng Fu
    Xiao Ma
    Feng Chen
    Shengli Xue
    Changgeng Ruan
    Wu Depei
    Xiaowen Tang
    BLOOD, 2014, 124 (21)
  • [50] TREATMENT OF RELAPSED ACUTE LEUKEMIA AFTER ALLO-HSCT BY SALVAGE CHEMOTHERAPY WITH LOW-DOSE CYTARABINE AND ACLARUBICIN COMBINED WITH G-CSF PRIMING: MORE EFFECTIVE AND LESS TOXIC?
    Zhou, H.
    Sun, A.
    Zhu, X.
    Qiu, H.
    Jin, Z.
    Miao, M.
    Fu, C.
    Ma, X.
    Chen, F.
    Xue, S.
    Ruan, C.
    Wu, D.
    Tang, X.
    HAEMATOLOGICA, 2014, 99 : 278 - 278